Write For Us

"Quality Issues Behind Covaxin Shortage": Government Vaccine Panel Chief | Reality Check

Sponsored Post Vitamin D2 Canada Persia
125 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
As the government struggles to ramp up the production of Covid shots to meet its target of vaccinating all adults by the year-end, the supply of Bharat Biotech's Covaxin has been slowed down by "quality issues" at the company's newest facility in Bengaluru, one of the government's top advisers has said. In an exclusive interview to NDTV, Covid task force member NK Arora admitted that the government was banking on a much sharper rise in the production of Covaxin – one of the two main vaccines in use in India – but was set back because of the quality issues at what is the company's biggest plant globally.

About Us: NDTV brings you unbiased and comprehensive coverage of news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Subscribe to our channels:
NDTV: https://www.youtube.com/user/ndtv?sub_confirmation=1
NDTV India (Hindi News): https://www.youtube.com/user/ndtvindia?sub_confirmation=1

Follow us on Social Media:
Like us on Facebook: https://www.facebook.com/ndtv/
Follow us on Twitter: https://twitter.com/ndtv/
Follow us on Instagram: https://www.instagram.com/ndtv/
Join NDTV on Telegram Messenger: https://t.me/NDTVbot/?start=hi

Follow us on Google News for Breaking and Latest News Updates:
NDTV: https://bit.ly/3e5ngbP
NDTV India (Hindi News): https://bit.ly/3mNVwMY

Download NDTV Mobile Apps:
http://www.ndtv.com/page/apps

Watch More Videos:
http://www.ndtv.com/video?yt

#BreakingNews #LatestNews #TodayNews #PoliticalNews #News
Category
Asia
Tags
NDTV 24x7, coronavirus, Covid Vaccine
Sign in or sign up to post comments.
Be the first to comment